A new drug target for liver cancer
National University of Singapore researchers have discovered that the MOAP-1 protein plays a role in reducing liver cancer risk by suppressing the hyper-active cancer-promoting Nrf2 cellular signaling pathway. Hepatocellular carcinoma (HCC), the primary form of liver cancer, is the fourth leading cause of cancer death worldwide. Although many risk factors and genetic aberrations have been […]
Continue Reading